Open Dialogue vs. NHS Care: Expert Reaction to Mental Health Trial

ODDESSI Trial Results Examine Open Dialogue vs. Standard NHS Mental Health Crisis Care

While the primary outcome of relapse reduction showed no significant difference, researchers noted reductions in initial hospital admissions and re-referrals alongside more positive patient care experiences. However, experts reviewing the data have urged caution regarding these secondary findings due to trial design limitations, unmasked participants, and lack of adjustment for multiple comparisons.

Understanding Open Dialogue vs. Traditional NHS Crisis Care

Open Dialogue originates from Western Lapland, Finland, and structures mental health services around network meetings that include patients, families, and social networks alongside continuous care from the same clinical team. According to Dr Sameer Jauhar, Clinical Associate Professor in Affective Disorders and Psychosis, Imperial College London and Consultant Psychiatrist, Brent Early Intervention Service, Central North West London NHS Foundation Trust, traditional mental health services often lack this continuity and integrated network approach, though core values like rapid access were once standard community mental health team practices before funding reductions.

Mark Hopfenbeck, Dialogue Room’s Associate Director, is a co-investigator on ODDESSI, notes that Open Dialogue integrates medication alongside listening and relationship building rather than withholding pharmaceutical interventions. Unlike standard therapy models that typically limit care to one individual seeing a single therapist weekly, Open Dialogue organizes an entire service framework around immediate access and family integration.

Key Findings and Methodological Limitations in the ODDESSI Trial

According to Dr Jauhar, the trial’s primary outcome showed that Open Dialogue failed to change the underlying course of illness or reduce relapse rates. Furthermore, secondary outcomes yielded several interpretive challenges. The reduction in hospital admissions occurred primarily within the first 14 days, pointing potentially to triage gatekeeping differences rather than therapeutic effects. Additionally, participant social networks showed no significant changes in size or quality, challenging the proposed mechanism of the intervention.

Prof Richard Morriss, Professor of Psychiatry, University of Nottingham, highlighted additional interpretive difficulties, noting that baseline crisis recovery definitions and timing lacked sufficient clarity for external replication. Because neither clinicians nor participants were masked to treatment allocations, expectations and triage practices likely influenced secondary outcomes like satisfaction and early discharge rates. Furthermore, post-COVID restrictions on face-to-face contact and potential staff contamination across treatment arms complicate the generalizability of the findings to current clinical practices.

Frequently Asked Questions

Did Open Dialogue reduce relapse rates in the ODDESSI trial?

No. According to the trial results published in The Lancet Psychiatry, Open Dialogue did not significantly reduce relapse rates compared to standard NHS treatments.

What positive outcomes were associated with Open Dialogue?

Participants experienced fewer initial hospital admissions, lower re-referral rates, and reported a more positive overall experience of care, though experts caution these secondary outcomes are exploratory.

Does Open Dialogue use psychiatric medication?

Yes. Open Dialogue incorporates medication alongside listening and relationship building rather than refusing pharmaceutical treatments.